In a post‑menopausal woman taking finasteride for female‑pattern hair loss, does losartan interact with finasteride?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Clinically Significant Drug Interaction Between Losartan and Finasteride

Losartan does not interact with finasteride, and these medications can be safely used together in a postmenopausal woman taking finasteride for female pattern hair loss.

Evidence from FDA Drug Labels

The FDA-approved drug label for finasteride explicitly states that no drug interactions of clinical importance have been identified 1. Finasteride does not affect the cytochrome P450-linked drug metabolizing enzyme system, and it was specifically tested with angiotensin-converting enzyme (ACE) inhibitors (the same drug class mechanism as ARBs like losartan) without evidence of clinically significant adverse interactions 1.

Similarly, the losartan FDA label lists specific drug interactions to monitor (potassium supplements, NSAIDs, lithium, other antihypertensives) but does not mention finasteride or 5α-reductase inhibitors as interacting medications 2.

Clinical Context for This Patient

Finasteride Use in Postmenopausal Women with FPHL

For this specific patient population, the evidence supports:

  • Finasteride 2.5-5 mg daily is the appropriate dose for postmenopausal women with female pattern hair loss 3
  • The 1 mg dose used in men is not effective in postmenopausal women 3, 4
  • Postmenopausal women show better response rates than premenopausal women, with 65-95% showing improvement 3, 5, 6
  • No contraception concerns exist in this postmenopausal patient, eliminating the primary safety concern with finasteride 3

Losartan Safety Profile

Losartan's main drug interactions involve:

  • Potassium-sparing medications (risk of hyperkalemia)
  • NSAIDs (reduced antihypertensive effect, kidney function)
  • Lithium (increased lithium levels)

None of these mechanisms overlap with finasteride's pharmacology.

Practical Management

You can confidently:

  • Continue both medications without dose adjustment
  • Monitor blood pressure and kidney function as indicated for losartan (standard monitoring)
  • Assess finasteride efficacy at 6-12 months for hair loss improvement
  • Watch for finasteride side effects (rare in postmenopausal women): potential liver enzyme elevation, though this occurred in only 1 of 40 patients in one study 5

Important Caveat

While there is no drug-drug interaction, both medications can affect blood pressure. Finasteride itself does not typically cause hypotension, but if the patient experiences dizziness, evaluate whether it's from losartan's antihypertensive effect rather than assuming an interaction.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.